Collier-Hyams Lauren S, Zeng Hui, Sun Jun, Tomlinson Amelia D, Bao Zhao Qin, Chen Huaqun, Madara James L, Orth Kim, Neish Andrew S
Epithelial Pathobiology Unit, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA.
J Immunol. 2002 Sep 15;169(6):2846-50. doi: 10.4049/jimmunol.169.6.2846.
Secreted prokaryotic effector proteins have evolved to modulate the cellular functions of specific eukaryotic hosts. Generally, these proteins are considered virulence factors that facilitate parasitism. However, in certain plant and insect eukaryotic/prokaryotic relationships, effector proteins are involved in the establishment of commensal or symbiotic interactions. In this study, we report that the AvrA protein from Salmonella typhimurium, a common enteropathogen of humans, is an effector molecule that inhibits activation of the key proinflammatory NF-kappaB transcription factor and augments apoptosis in human epithelial cells. This activity is similar but mechanistically distinct from that described for YopJ, an AvrA homolog expressed by the bacterial pathogen Yersinia. We suggest that AvrA may limit virulence in vertebrates in a manner analogous to avirulence factors in plants, and as such, is the first bacterial effector from a mammalian pathogen that has been ascribed such a function.
分泌型原核效应蛋白已经进化到能够调节特定真核宿主的细胞功能。一般来说,这些蛋白被认为是促进寄生作用的毒力因子。然而,在某些植物和昆虫的真核/原核关系中,效应蛋白参与了共生或共生相互作用的建立。在本研究中,我们报告了来自鼠伤寒沙门氏菌(一种常见的人类肠道病原体)的AvrA蛋白是一种效应分子,它能抑制关键促炎NF-κB转录因子的激活,并增强人上皮细胞的凋亡。这种活性与细菌病原体耶尔森氏菌表达的AvrA同源物YopJ所描述的活性相似,但机制不同。我们认为,AvrA可能以类似于植物无毒因子的方式限制脊椎动物的毒力,因此,它是第一个被赋予这种功能的来自哺乳动物病原体的细菌效应蛋白。